Impact of escitalopram on nocturnal sleep, daytime sleepiness and performance compared to amitriptyline: A randomized, double-blind, placebo-controlled study in healthy male subjects.

Trial Profile

Impact of escitalopram on nocturnal sleep, daytime sleepiness and performance compared to amitriptyline: A randomized, double-blind, placebo-controlled study in healthy male subjects.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Sep 2016

At a glance

  • Drugs Escitalopram (Primary) ; Amitriptyline
  • Indications Anxiety disorders; Depressive disorders; Sleep disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 06 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top